10.1038/90950
10.1038/90950 · doi-reference
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
10.1002/trc2.12283 · doi-reference
10.1093/jalm/jfaa171
10.1093/jalm/jfaa171 · doi-reference
10.1177/1073858420908189
10.1177/1073858420908189 · doi-reference
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
10.3389/fnagi.2022.932676 · doi-reference
Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer's disease based on interpretable machine learning
10.3389/fphar.2022.975774 · doi-reference
Identification of diagnostic signatures associated with immune infiltration in Alzheimer's disease by integrating bioinformatic analysis and machine-learning strategies
10.3389/fnagi.2022.919614 · doi-reference
Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease
10.3389/fimmu.2023.1182307 · doi-reference
Detecting diagnostic biomarkers of Alzheimer's disease by integrating gene expression data in six brain regions
10.3389/fgene.2019.00157 · doi-reference
10.1038/s41588-018-0311-9
10.1038/s41588-018-0311-9 · doi-reference
Genome-wide association studies for Alzheimer's disease: bigger is not always better
10.1093/braincomms/fcac125 · doi-reference
Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging
10.1073/pnas.192585799 · doi-reference
10.1038/s41590-020-0725-2
10.1038/s41590-020-0725-2 · doi-reference
10.1111/febs.15327
10.1111/febs.15327 · doi-reference
10.1038/nri.2017.66
10.1038/nri.2017.66 · doi-reference
10.1002/1873-3468.12890
10.1002/1873-3468.12890 · doi-reference
10.18632/aging.102438
10.18632/aging.102438 · doi-reference
IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca2+ through the noncanonical STAT3 pathway
10.1073/pnas.2103444118 · doi-reference
p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells
10.1172/jci75051 · doi-reference
Mitochondrial dysfunction in CD4+ T effector memory RA+ cells
10.3390/biology12040597 · doi-reference
Mitochondrial depletion in CD4+ and CD19+ peripheral lymphocytes in early stage Alzheimer's disease
10.1016/j.mad.2017.09.003 · doi-reference
Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases
10.3389/fncel.2018.00114 · doi-reference
Effects of mitochondrial dysfunction on the immunological properties of microglia
10.1186/1742-2094-7-45 · doi-reference
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer's disease
10.1007/s10072-019-03863-x · doi-reference
Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain
10.1016/j.mad.2016.05.005 · doi-reference
10.1016/j.freeradbiomed.2020.12.009
10.1016/j.freeradbiomed.2020.12.009 · doi-reference
10.1038/nm.3758
10.1038/nm.3758 · doi-reference
10.1016/j.immuni.2012.10.020
10.1016/j.immuni.2012.10.020 · doi-reference
10.1083/jcb.201709172
10.1083/jcb.201709172 · doi-reference
10.1172/jci120848
10.1172/jci120848 · doi-reference
The association of tau with mitochondrial dysfunction in Alzheimer's disease
10.3389/fnins.2018.00163 · doi-reference
Mechanisms of mitochondrial dysfunction in Alzheimer's disease
10.1007/s12035-015-9515-5 · doi-reference
The role of mitochondrial dysfunction in the progression of Alzheimer's disease
10.2174/0929867324666170616110111 · doi-reference
Activated bone marrow-derived macrophages eradicate Alzheimer's-related Aβ42 oligomers and protect synapses
10.3389/fimmu.2020.00049 · doi-reference
Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8+ T cell function by limiting GSH and Cys availability
10.1016/j.freeradbiomed.2015.02.004 · doi-reference
10.3390/ijms18122772
10.3390/ijms18122772 · doi-reference
A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer's and Parkinson's diseases
10.3389/fncel.2021.787258 · doi-reference
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
10.1016/j.redox.2017.07.006 · doi-reference
10.3390/antiox10071069
10.3390/antiox10071069 · doi-reference
Nrf2: a dark horse in Alzheimer's disease treatment
10.1016/j.arr.2020.101206 · doi-reference
